Form 4: Clorox CFO Luc Bellet Acquires 7,368 Shares

Clorox Company's EVP and Chief Financial Officer, Luc Bellet, acquired 7,368 shares of common stock at $124.85 per share, increasing his direct beneficial ownership to 19,546 shares.

Summary

• Luc Bellet, EVP and Chief Financial Officer of The Clorox Company, acquired 7,368 shares of common stock.
• The transaction occurred on September 16, 2025, at a price of $124.85 per share.
• Following this acquisition, Bellet directly beneficially owns 19,546 shares of Clorox common stock.
• The acquired shares are Restricted Stock Units (RSUs) that will vest in four equal installments on October 5, 2026, 2027, 2028, and 2029.
• The transaction was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 6

Explanation: The acquisition of shares by a key executive, especially under a 10b5-1 plan, is generally viewed as a neutral to slightly positive signal, indicating management's continued alignment with shareholder interests and confidence in the company's long-term value.

Positives

• Insider acquisition of shares by a key executive (CFO) can signal confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned, non-discretionary acquisition.

Future Outlook

The Restricted Stock Units are scheduled to vest in four equal installments annually from October 5, 2026, through October 5, 2029, indicating a long-term incentive structure for the executive.

Management Comments

• "This letter authorizes the following representatives of The Clorox Company, acting singly, to execute and file with you on my behalf future Forms 3, 4 and 5 respecting my holdings of equity securities of The Clorox Company." (From Luc Bellet's authorization letter)

Industry Context

Insider transactions, particularly acquisitions by senior executives, are often monitored by investors as they can provide insights into management's perception of the company's value and future prospects. Such transactions are common components of executive compensation packages.

Comparison to Industry Standards

• This filing reports a standard insider transaction, often part of executive compensation or a pre-planned trading strategy, and does not provide sufficient data for a direct comparison to specific industry benchmarks or competitor results.

Corporate Governance

Related Party Transactions

• Acquisition of 7,368 shares of common stock by Luc Bellet, EVP and Chief Financial Officer, as part of his beneficial ownership and executive compensation.

Stakeholder Impact

• Shareholders: Increased insider ownership may align management's interests more closely with shareholders, potentially signaling confidence in future performance.
• Employees: The RSU vesting schedule provides long-term incentives for a key executive.

Next Steps

• Vesting of Restricted Stock Units on October 5, 2026.
• Vesting of Restricted Stock Units on October 5, 2027.
• Vesting of Restricted Stock Units on October 5, 2028.
• Vesting of Restricted Stock Units on October 5, 2029.

Key Dates

Recommendation

While insider buying can be a positive signal, a single Form 4 filing, especially one related to RSU vesting or a 10b5-1 plan, typically does not provide enough information to warrant a strong buy or sell recommendation. It primarily indicates continued executive alignment and participation in equity compensation.

Keywords

Clorox, CLX, Luc Bellet, CFO, insider transaction, Form 4, stock acquisition, RSU, 10b5-1 plan, beneficial ownership